Ferven Limited
Registered name: FERVEN LIMITED
Part of Alterola Biotech Inc groupFerven Limited made a £18k loss in the year to 31 Mar 2025 (revenue not disclosed).
Ferven Limited reported a loss of £18k in the year to 31 Mar 2025; its revenue was not disclosed. It had 3 employees. The company is classified under “manufacture of pharmaceutical preparations” and is based in Pulford; we hold 4 years of its filed accounts.
- Status
- Active
- Location
- Pulford, North West
- Age
- 13 yrs · since 2012
- Type
- Private Limited Company
Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently.
Key figures
This company published its profit but not its turnover, so revenue and margins are not disclosed. We never estimate them.
Badges are automated estimates derived from the filed figures — not statements of fact about the company.
Financial history
| Year to | 31 Mar 2022 | 31 Mar 2023 | 31 Mar 2024 | 31 Mar 2025 |
|---|---|---|---|---|
| Disclosure | No P&L | No P&L | Profit only | Profit only |
| Profit & loss | ||||
| Revenue (turnover) | — | — | — | — |
| Operating profit | — | — | −£22 | −£18k |
| Profit before tax | — | — | −£22 | −£18k |
| Profit after tax | — | — | −£22 | −£18k |
| Profit (best available) | — | — | −£22 | −£18k |
| Employees (average) | 4 | 3 | 3 | 3 |
| Ratios | ||||
| Profit margin | — | — | — | — |
| Profit per employee | — | — | −£7 | −£6k |
| Growth (year on year) | ||||
| Headcount growth | — | ▼25% | 0% | 0% |
| Balance sheet — indirect signals, not revenue | ||||
| Cash at bank | £78 | £157 | £135 | £135 |
| Net assets | −£115k | −£173k | −£173k | −£191k |
| Current assets | £55.2k | £28.1k | £28k | £28k |
| Debtors | £55.2k | £27.9k | £27.9k | £27.9k |
| Source | FullAccounts · bulk data Mar 2024 | FullAccounts · bulk data Mar 2024 | FullAccounts · bulk data Dec 2024 | FullAccounts · bulk data Dec 2025 |
How the business works
- Profit margin
- —
- Profit ÷ revenue.
- Gross margin
- —
- Gross profit ÷ revenue. High for software and services.
- Revenue per employee
- —
- Revenue ÷ average employees.
- Profit per employee
- −£6k
- Profit ÷ average employees.
- Cash conversion
- —
- Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
- Fixed assets ÷ revenue
- —
- Capital intensity. Low = capital-light, cheaper to start.
- Deferred income ÷ revenue
- —
- Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
- Debtors ÷ revenue
- —
- Money owed by customers. Low = customers pay quickly.
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- —
- Now −£191k
- Cash at bank
- 0%
- Now £135
- Headcount
- 0%
- Now 3
- Deferred income
- —
- Now —
- Fixed assets
- —
- Now —
Group structure
Ownership chain
- Alterola Biotech Inc (registered outside the UK register)ultimate parent75–100%
- Abti Pharma Limited75–100%
- Ferven Limitedthis company
Bands show the share of ownership each company holds in the one below it.
Sister companies (1)
- Phytotherapeutix LtdRev. — · Profit −£1.3k
From the Persons with Significant Control register (corporate controllers only).
Similar profitable businesses
- Nicobrand LimitedCounty Londonderry · Manufacture of pharmaceutical preparations
- Revenue
- £62.5m
- Profit
- £19.9m
- Staff
- 88
- Catalent CTS (Edinburgh) LimitedSwindon · Manufacture of pharmaceutical preparations
- Revenue
- £68.7m
- Profit
- £17.8m
- Staff
- 264
- Morningside Pharmaceuticals LimitedNorthampton · Manufacture of pharmaceutical preparations
- Revenue
- £75.3m
- Profit
- £13.4m
- Staff
- 47
- Morningside Healthcare LimitedNorthampton · Manufacture of pharmaceutical preparations
- Revenue
- £21.3m
- Profit
- £10.5m
- Staff
- 10
- DR Reddy's Laboratories (UK) LimitedCambridge · Manufacture of pharmaceutical preparations
- Revenue
- £95m
- Profit
- £10.1m
- Staff
- 46
- Quantum Pharmaceutical LimitedBurnopfield · Manufacture of pharmaceutical preparations
- Revenue
- £235m
- Profit
- £8.6m
- Staff
- 279
Sources
Latest figures from FullAccounts for the year to 31 Mar 2025 (profit −£18k), from the Companies House accounts bulk data published Dec 2025. Spotted an error? Request a correction.
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.